
Thomas' Hematopoietic Cell Transplantation
by Appelbaum, Frederick R.; Forman, Stephen J; Negrin, Robert S.; Blume, Karl G.Rent Textbook
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Author Biography
Stephen J. Forman, MD, Director, Department of Hematology and Bone Marrow Transplantation; Staff Physician, Division of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Karl G. Blume, MD, Professor of Medicine, Division of Bone Marrow Transplantation, Department of Medicine, Stanford University, Stanford, California, USA.
Robert S. Negrin, MD, Associate Professor of Medicine, Division of Bone Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Table of Contents
1A History of Bone Marrow Transplantation | |
Uses and Growth of Hematopoietic Cell Transplantation | |
Overview of Hematopoietic Cell Transplantation Immunology | |
Histocompatibility | |
Functional Evolution of the Major Histocompatibility Complex | |
The Hematopoietic Microenvironment | |
Molecular Aspects of Stem Cell Renewal | |
Biology of Hematopoietic Stem and Progenitor Cells | |
Expansion of Hematopoietic Stem Cells | |
Methods for Gene Transfer: Genetic Manipulation of Hematopoietic Stem Cells | |
Clinical Trials of Gene Marking and Gene Therapy Using Hematopoietic Stem Cells | |
Pharmacological Basis for High-Dose Chemotherapy | |
Preparative Regimens and Modification of Regimen-Related Toxicities | |
Radiotherapeutic Principles of Hematopoietic Cell Transplantation | |
Radioimmunotherapy and Hematopoietic Cell Transplantation | |
Pharmacology and the Use of Immunosuppressive Agents after Hematopoietic Cell Transplantation | |
T-Cell Depletion to Prevent Graft-vs.-Host Disease | |
Documentation of Engraftment and Characterization of Chimerism Following Hematopoietic Cell Transplantation | |
Antibody Mediated Purging | |
Pharmacologic Purging of Bone Marrow | |
Molecular Inhibition of Gene Expression in Hematopoietic Cells | |
The Detection and Significance of Minimal Residual Disease | |
Pathology of Hematopoietic Cell Transplantation | |
Mechanisms of Tolerance | |
The Experimental Basis for Hematopoietic Cell Transplantation for Autoimmune Diseases | |
Murine Models for Graft-vs.-Host Disease | |
The Pathophysiology of Graft-vs.-Host Disease | |
Graft-versus-Tumor Responses | |
Adoptive Immunotherapy with Antigen-Specific T Cells | |
Autologous Graft-vs.-Host Disease | |
Biostatistical Methods in Hematopoietic Cell Transplantation | |
Outcomes Research in Hematopoietic Cell Transplantation | |
The Evaluation and Counseling of Candidates for Hematopoietic Cell Transplantation | |
Clinical and Administrative Support for Hematopoietic Cell Transplant Programs | |
Nursing Issues in Hematopoietic Cell Transplantation | |
The PatientÆs Perspective | |
Ethical Issues in Hematopoietic Cell Transplantation | |
Psychosocial Issues in Hematopoietic Cell Transplantation | |
Assessment of Quality of Life in Hematopoietic Cell Transplantation Recipients, 507 | |
Sexuality after Hematopoietic Cell Transplantation | |
Hematopoietic Cell Procurement, Processing and Transplantation: Regulation and Accreditation | |
Hematopoietic Cell Donors | |
Cord Blood Hematopoietic Cell Transplantation | |
In Utero Transplantation | |
Mobilization of Autologous Peripheral Blood Hematopoietic Cells for Support of High-Dose Cancer Therapy | |
Peripheral Blood Hematopoietic Cells for Allogeneic Transplantation | |
Cryopreservation of Hematopoietic Cell | |
Recombinant Growth Factors after Hematopoietic Cell Transplantation | |
Hematopoietic Cell Donor Registries | |
Graft-vs.-Host Disease | |
Bacterial Infections | |
Fungal Infections after Hematopoietic Cell Transplantation | |
Cytomegalovirus Infection | |
Herpes Simplex Virus Infections | |
Varicella-Zoster Virus Infections | |
Epstein-Barr Virus Infection | |
Other Viral Infections after Hematopoietic Cell Transplantation | |
Gastrointestinal and Hepatic Complications | |
Neurological Complications of Hematopoietic Cell Transplantation | |
Blood Group Incompatibilities and Hemolytic Complications of Hematopoietic Cell Transplantation | |
Principles of Transfusion Support before and after Hematopoietic Cell Transplantation | |
Immunological Reconstitution following Hematopoietic Cell Transplantation | |
Vaccination of Hematopoietic Cell Transplant Recipients | |
Pulmonary Complications after Hematopoietic Cell Transplantation | |
Nutritional Support of Hematopoietic Cell Recipients | |
Pain Management | |
Oral Complications | |
Growth and Development after Hematopoietic Cell Transplantation | |
Delayed Complications after Hematopoietic Cell Transplantation | |
Secondary Malignancies after Hematopoietic Cell Transplantation | |
Allogeneic Hematopoietic Cell Transplantation for Aplastic Anemia | |
Allogeneic Transplantation for Paroxysmal Nocturnal Hemoglobinuria | |
Allogeneic Transplantation for Chronic Myeloid Leukemia | |
Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia | |
Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myeloid Leukemia | |
Allogeneic Transplantation for Acute Myeloid Leukemia in Children | |
Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults | |
Allogeneic Transplantation for Acute Lymphoblastic Leukemia in Children | |
Allogeneic Transplantation for Myelodysplastic and Myeloproliferative Disorders | |
Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma | |
Allogeneic Transplantation for Lymphoma and Chronic Lymphocytic Leukemia | |
Hematopoietic Cell Transplantation from HLA Partially Matched Related Donors | |
Hematopoietic Cell Transplantation from Unrelated Donors | |
Management of Relapse after Allogeneic Transplantation | |
Nonmyeloablative Therapy and Hematopoietic Cell Transplantation for Hematologic Disorders | |
Allogeneic Hematopoietic Cell Transplantation for Solid Tumors | |
Autologous and Allogeneic Hematopoietic Cell Transplantation for HodgkinÆs Disease | |
Autologous Hematopoietic Cell Transplantation for Non-HodgkinÆs Lymphoma | |
Autologous Hematopoietic Cell Transplantation for Acute Myeloid Leukemia | |
Autologous Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia | |
Autologous Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia | |
Autologous Hematopoietic Cell Transplantation for Multiple Myeloma | |
Autologous Hematopoietic Cell Transplantation for AL Amyloidosis | |
Hematopoietic Cell Transplantation for Breast Cancer | |
Hematopoietic Cell Transplantation in Germ Cell Tumors | |
Hematopoietic Cell Transplantation in Ovarian Carcinoma | |
Hematopoietic Cell Transplantation for Neuroblastoma | |
Hematopoietic Cell Transplantation for Brain Tumors | |
Hematopoietic Cell Transplantation for Pediatric Patients with Solid Tumors | |
AIDS and Hematopoietic Transplantation: HIV Infection, AIDS, Lymphoma and Gene Therapy | |
Hematopoietic Stem Cell Transplantation for Autoimmune Diseases | |
Prevention and Therapy of Relapse following Autologous Hematopoietic Cell Transplantation | |
Marrow Transplantation in Thalassemia | |
Hematopoietic Cell Transplantation for Sickle Cell Disease | |
Hematopoietic Cell Transplantation for Immunodeficiency Diseases | |
Hematopoietic Cell Transplantation for Osteopetrosis | |
Hematopoietic Cell Transplantation for Storage Diseases | |
Hematopoietic Cell Transplantation for Macrophage and Granulocyte Disorders | |
Hematopoietic Cell Transplantation for Fanconi Anemia | |
Hematopoietic Cell Transplantation in the 21st Century | |
Ernest Beutler | |
Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.